查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1424428

细胞膜穿透胜胜肽的全球市场：按类型、按应用、按最终用户、按地区

Global Cell Penetrating Peptide Market, By Type, By Application, By End User (Biopharmaceutical Companies, Contract Research Organization /CDMO, Hospitals and Clinics, Others), By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 179 Pages | 商品交期: 2-3个工作天内

价格
简介目录

细胞膜穿透胜胜肽的全球市场规模预计将从 2023 年的 29.4 亿美元增加到 2030 年的 84 亿美元，预测期内复合年增长率为 16.2%。

报告范围 报告详情
基准年 2022年 2023/2024年市场规模 29.4亿美元
实际资料 2017年至2021年 预测期 2023-2030
预测期间 2023/2024 至 2030/2031 年复合年增长率： 16.20% 2030/2031价值预测 84亿美元
图 1. 2023 年细胞膜穿透胜胜肽的全球市场占有率（%），依地区划分
全球细胞穿透胜肽市场-IMG1

细胞膜穿透胜胜肽（CPP）是短胺基酸序列，可穿过细胞膜并将抗体、核酸和化疗药物等生物活性物质递送到细胞内。它具有跨越屏障的能力，能够输送多种临床实验和核准的治疗药物，使其成为重要的分子转运蛋白。该市场正在进行大量研究，以优化细胞膜穿透胜胜肽（CPP）的序列和缀合技术，以提高其药理特性，如稳定性、溶解度和细胞摄取效率。随着人们对开发基于 CPP 的治疗神经退化疾病和慢性感染疾病等疾病的发行策略的兴趣日益浓厚，细胞穿透胜胜肽市场预计将在未来几年快速增长。

与传统转染方法相比，CPP 具有许多优势，因为它可以在生理条件下非侵入性、高效、快速地将货物分子递送至活细胞。由于其易于分子结合和高度生物相容性吸收，CPP 在蛋白质治疗、基因转移和诊断成像等研究和治疗应用中具有巨大潜力。然而，其非选择性双层破坏和高浓度下可能的细胞毒性仍然是主要挑战。改进的设计策略旨在开发更安全、更有特异性的CPP。

市场动态：

细胞膜穿透胜胜肽市场的驱动因素包括癌症等需要细胞内递送治疗药物的疾病的增加、研发的进步、製药公司的投资以及胜肽类药物的采用增加。然而，与某些 CPP 相关的挑战，例如稳定性差、不可预测的毒性和免疫反应抑制等，正在阻碍市场成长。继续研究开发新一代无毒且生物相容的胜肽序列提供了重大机会。

本研究的主要特点

  • 本报告对全球细胞膜穿透胜胜肽市场进行了详细分析，并列出了以2022年为基准年的预测期（2023-2030年）的市场规模和年复合成长率（CAGR%）。
  • 它还揭示了各个细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球细胞膜穿透胜胜肽市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
  • 本研究报告针对该产业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过分析全球细胞膜穿透胜胜肽市场时所使用的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 监管场景
  • 服务交付组合
  • PEST分析
  • 波特的分析
  • 併购场景
  • 管道分析

第四章全球细胞膜穿透胜胜肽市场 -冠状病毒（COVID-19）大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章2018-2030年全球细胞膜穿透胜胜肽市场（依类型）

  • 源自蛋白质的 CPP
  • 合成CPP
  • 嵌合体CPP

第六章 2018-2030 年全球细胞膜穿透胜胜肽市场（依应用）

  • 药物输送
  • 基因转移
  • 诊断
  • 分子影像
  • 其他的

第 7 章 全球细胞膜穿透胜胜肽市场，依最终用户划分，2018-2030 年

  • 生物製药公司
  • 合约研究组织 (CRO)/CDMO
  • 医院和诊所
  • 其他的

第八章2018-2030年全球细胞膜穿透胜胜肽市场（按地区）

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 竞争形势

  • AnaSpec
  • Peptomyc
  • BioAlps
  • Sarepta Therapeutics, Inc.
  • REVANCE THERAPEUTICS
  • PolyPeptide Group
  • Bachem
  • Pepscan
  • Creative Peptides
  • Cupidpeptides
  • AltaBioscience Ltd

第10章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6553

The global cell penetrating peptide market size is expected to reach US$ 8.40 Bn by 2030, from US$ 2.94 Bn in 2023, exhibiting a CAGR of 16.2% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023/2024: US$ 2.94 Bn
Historical Data for: 2017 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR: 16.20% 2030/2031 Value Projection: US$ 8.40 Bn
Figure 1. Global Cell Penetrating Peptide Market Share (%), By Region, 2023
Global Cell Penetrating Peptide Market - IMG1

Cell penetrating peptides (CPPs) are short sequences of amino acids that are able to cross cell membranes and deliver attached bioactive cargo such as antibodies, nucleic acids, and chemotherapeutics into cells. Their ability to traverse barriers has made them important molecular transporters, enabling the delivery of various investigational and approved therapeutics. The market has witnessed considerable research on optimizing Cell penetrating peptides (CPPs) sequences and conjugation techniques to improve pharmacological properties such as stability, solubility, and cellular uptake efficiency. With growing interest in developing CPP-based delivery strategies for diseases like cancer, neurodegeneration, and chronic infections, the cell penetrating peptide market is anticipated to grow at a rapid pace in the future.

CPPs offer numerous advantages over traditional transfection methods as they provide a non-invasive, efficient, and rapid delivery of cargo molecules into live cells under physiological conditions. Given their easy molecular conjugation and biocompatible uptake, CPPs hold immense potential for research and therapeutic applications including protein therapy, gene delivery, and diagnostic imaging. However, their non-selective bilayer disruption and possible cytotoxicity at higher concentrations remain major challenges. Improved design strategies aim to develop safer and more target-specific CPPs.

Market Dynamics:

The cell penetrating peptide market is driven by rising incidences of diseases such as cancer and others requiring intracellular delivery of therapeutics, increasing research and development, investments by pharmaceutical companies, and growing adoption of peptide-based drugs. However, challenges pertaining to poor stability, unpredictable toxicity, and immune response inhibition associated with some CPPs hamper market growth. Ongoing research to engineer newer generations of non-toxic and biocompatible peptide sequences presents significant opportunities.

Thus, the increasing prevalence of cancer is expected to propel market growth over the forecast period. For instance, according to the data published by the American Cancer Society in 2021, cancer facts and figures in the U.S. reported the estimated number of cancer cases in the U.S. in 2021, which is provided below:

ESTIMATED NEW CANCER CASES IN THE U.S. IN 2021

    • Female Breast Cancer-281,550
    • Lung & bronchus- 235,760
    • Melanoma of the skin- 106,110
    • Urinary bladder- 83,730
    • Prostate-248,530
    • Colon & rectum- 149,500
    • Uterine cervix-281,550
    • Uterine- 149,500
    • corpus Leukemia- 61,090
    • Non Hodgkin lymphoma- 81,560

Key features of the study:

  • This report provides in-depth analysis of the global cell penetrating peptide market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cell penetrating peptide market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include AnaSpec, Peptomyc, BioAlps, Sarepta Therapeutics, Inc., REVANCE THERAPEUTICS, PolyPeptide Group, Bachem, Pepscan Creative Peptides, Cupidpeptides and AltaBioscience Ltd
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global cell penetrating peptide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell penetrating peptide market

Detailed Segmentation:

  • Global Cell Penetrating Peptide Market, By Type
    • Protein Derived CPPs
    • Synthetic CPPs
    • Chimeric CPPs
  • Global Cell Penetrating Peptide Market, By Application
    • Drug Delivery
    • Gene Delivery
    • Diagnostics
    • Molecular Imaging
    • Others
  • Global Cell Penetrating Peptide Market, By End User
    • Biopharmaceutical Companies
    • Contract Research Organization (CROs)/CDMO
    • Hospitals and Clinics
    • Others
  • Global Cell Penetrating Peptide Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Global Cell Penetrating Peptide Market, Key Players
    • AnaSpec
    • Peptomyc
    • BioAlps
    • Sarepta Therapeutics, Inc.
    • REVANCE THERAPEUTICS
    • PolyPeptide Group
    • Bachem
    • Pepscan
    • Creative Peptides
    • Cupidpeptides
    • AltaBioscience Ltd¬

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Cell Penetrating Peptide Market, By Type
    • Global Cell Penetrating Peptide Market, By Application
    • Global Cell Penetrating Peptide Market, By End User
    • Global Cell Penetrating Peptide Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Expanding Applications in Regenerative Medicine
    • Low drug encapsulation efficiency
    • Increasing applications of CPPs in therapeutics development
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Service offering Portfolio
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Pipeline Analysis

4. Global Cell Penetrating Peptide Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Cell Penetrating Peptide Market, By Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Protein Derived CPPs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Synthetic CPPs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Chimeric CPPs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Cell Penetrating Peptide Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Drug Delivery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Gene Delivery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Molecular Imaging
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global Cell Penetrating Peptide Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Biopharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Contract Research Organization (CROs)/CDMO
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global Cell Penetrating Peptide Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2019 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • AnaSpec
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Peptomyc
  • BioAlps
  • Sarepta Therapeutics, Inc.
  • REVANCE THERAPEUTICS
  • PolyPeptide Group
  • Bachem
  • Pepscan
  • Creative Peptides
  • Cupidpeptides
  • AltaBioscience Ltd
  • Analyst Views

10. Section

  • Research Methodology
  • About us